Serum Calprotectin in Adolescents With Inflammatory Bowel Disease: A Pilot Investigation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Serum Calprotectin in Adolescents With Inflammatory Bowel Disease : A Pilot Investigation. / Carlsen, Katrine; Malham, Mikkel; Hansen, Lars Folmer; Petersen, Jens Jakob Herrche; Paerregaard, Anders; Houen, Gunnar; Wewer, Vibeke.

I: Journal of Pediatric Gastroenterology and Nutrition, Bind 68, Nr. 5, 05.2019, s. 669-675.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Carlsen, K, Malham, M, Hansen, LF, Petersen, JJH, Paerregaard, A, Houen, G & Wewer, V 2019, 'Serum Calprotectin in Adolescents With Inflammatory Bowel Disease: A Pilot Investigation', Journal of Pediatric Gastroenterology and Nutrition, bind 68, nr. 5, s. 669-675. https://doi.org/10.1097/MPG.0000000000002244

APA

Carlsen, K., Malham, M., Hansen, L. F., Petersen, J. J. H., Paerregaard, A., Houen, G., & Wewer, V. (2019). Serum Calprotectin in Adolescents With Inflammatory Bowel Disease: A Pilot Investigation. Journal of Pediatric Gastroenterology and Nutrition, 68(5), 669-675. https://doi.org/10.1097/MPG.0000000000002244

Vancouver

Carlsen K, Malham M, Hansen LF, Petersen JJH, Paerregaard A, Houen G o.a. Serum Calprotectin in Adolescents With Inflammatory Bowel Disease: A Pilot Investigation. Journal of Pediatric Gastroenterology and Nutrition. 2019 maj;68(5):669-675. https://doi.org/10.1097/MPG.0000000000002244

Author

Carlsen, Katrine ; Malham, Mikkel ; Hansen, Lars Folmer ; Petersen, Jens Jakob Herrche ; Paerregaard, Anders ; Houen, Gunnar ; Wewer, Vibeke. / Serum Calprotectin in Adolescents With Inflammatory Bowel Disease : A Pilot Investigation. I: Journal of Pediatric Gastroenterology and Nutrition. 2019 ; Bind 68, Nr. 5. s. 669-675.

Bibtex

@article{0f81cc59931b4de18d61407f10b97481,
title = "Serum Calprotectin in Adolescents With Inflammatory Bowel Disease: A Pilot Investigation",
abstract = "Objectives:Fecal calprotectin (FC) is a well-integrated parameter in the monitoring of adolescent patients with inflammatory bowel disease (IBD). However, measurement of FC is limited by day-To-day-variation and by the feces consistency. Furthermore, adolescents are often noncompliant to deliver fecal sampling leading to suboptimal monitoring. Consequently, we see the need of a substitute biomarker whenever measurement of FC fails and aimed to investigate serum calprotectin (SC) in adolescents with IBD.Methods:In cross sectional data from 19 ulcerative colitis (UC) patients <18 years old, a Spearman correlation was used to analyze the correlation between SC, FC, C-reactive protein (CRP) and endoscopic and symptom scores. In longitudinal data collected from 20 UC and Crohn disease (CD) patients (10-17 years old), Mixed Effect Models (MEM) were used to analyze the association between SC, FC, CRP, and symptom scores.Results:We found positive correlations between SC (19 samples) and the endoscopic score, symptom score, and CRP (r=0.56, P=0.01; r=0.64, P=0.003; r=0.97, P<0.0001). We found no significant correlation between SC and FC. In 27 samples from UC patients, the association of SC with FC and CRP were positive and significant (P=0.004, estimate=0.32; P=0.0001, estimate=0.002). The association between SC and symptom score was insignificant. In 49 samples from CD patients, the association between SC and CRP was significant (P=0.02, estimate=0.002) whereas associations between SC and FC and symptom score were insignificant.Conclusions:In the current pilot study, we found a correlation between SC and the endoscopically assessed inflammation in UC. SC may have the potential to improve disease monitoring of adolescent patients.",
keywords = "endoscopy, fecal calprotectin, symptom score",
author = "Katrine Carlsen and Mikkel Malham and Hansen, {Lars Folmer} and Petersen, {Jens Jakob Herrche} and Anders Paerregaard and Gunnar Houen and Vibeke Wewer",
year = "2019",
month = may,
doi = "10.1097/MPG.0000000000002244",
language = "English",
volume = "68",
pages = "669--675",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams & Wilkins",
number = "5",

}

RIS

TY - JOUR

T1 - Serum Calprotectin in Adolescents With Inflammatory Bowel Disease

T2 - A Pilot Investigation

AU - Carlsen, Katrine

AU - Malham, Mikkel

AU - Hansen, Lars Folmer

AU - Petersen, Jens Jakob Herrche

AU - Paerregaard, Anders

AU - Houen, Gunnar

AU - Wewer, Vibeke

PY - 2019/5

Y1 - 2019/5

N2 - Objectives:Fecal calprotectin (FC) is a well-integrated parameter in the monitoring of adolescent patients with inflammatory bowel disease (IBD). However, measurement of FC is limited by day-To-day-variation and by the feces consistency. Furthermore, adolescents are often noncompliant to deliver fecal sampling leading to suboptimal monitoring. Consequently, we see the need of a substitute biomarker whenever measurement of FC fails and aimed to investigate serum calprotectin (SC) in adolescents with IBD.Methods:In cross sectional data from 19 ulcerative colitis (UC) patients <18 years old, a Spearman correlation was used to analyze the correlation between SC, FC, C-reactive protein (CRP) and endoscopic and symptom scores. In longitudinal data collected from 20 UC and Crohn disease (CD) patients (10-17 years old), Mixed Effect Models (MEM) were used to analyze the association between SC, FC, CRP, and symptom scores.Results:We found positive correlations between SC (19 samples) and the endoscopic score, symptom score, and CRP (r=0.56, P=0.01; r=0.64, P=0.003; r=0.97, P<0.0001). We found no significant correlation between SC and FC. In 27 samples from UC patients, the association of SC with FC and CRP were positive and significant (P=0.004, estimate=0.32; P=0.0001, estimate=0.002). The association between SC and symptom score was insignificant. In 49 samples from CD patients, the association between SC and CRP was significant (P=0.02, estimate=0.002) whereas associations between SC and FC and symptom score were insignificant.Conclusions:In the current pilot study, we found a correlation between SC and the endoscopically assessed inflammation in UC. SC may have the potential to improve disease monitoring of adolescent patients.

AB - Objectives:Fecal calprotectin (FC) is a well-integrated parameter in the monitoring of adolescent patients with inflammatory bowel disease (IBD). However, measurement of FC is limited by day-To-day-variation and by the feces consistency. Furthermore, adolescents are often noncompliant to deliver fecal sampling leading to suboptimal monitoring. Consequently, we see the need of a substitute biomarker whenever measurement of FC fails and aimed to investigate serum calprotectin (SC) in adolescents with IBD.Methods:In cross sectional data from 19 ulcerative colitis (UC) patients <18 years old, a Spearman correlation was used to analyze the correlation between SC, FC, C-reactive protein (CRP) and endoscopic and symptom scores. In longitudinal data collected from 20 UC and Crohn disease (CD) patients (10-17 years old), Mixed Effect Models (MEM) were used to analyze the association between SC, FC, CRP, and symptom scores.Results:We found positive correlations between SC (19 samples) and the endoscopic score, symptom score, and CRP (r=0.56, P=0.01; r=0.64, P=0.003; r=0.97, P<0.0001). We found no significant correlation between SC and FC. In 27 samples from UC patients, the association of SC with FC and CRP were positive and significant (P=0.004, estimate=0.32; P=0.0001, estimate=0.002). The association between SC and symptom score was insignificant. In 49 samples from CD patients, the association between SC and CRP was significant (P=0.02, estimate=0.002) whereas associations between SC and FC and symptom score were insignificant.Conclusions:In the current pilot study, we found a correlation between SC and the endoscopically assessed inflammation in UC. SC may have the potential to improve disease monitoring of adolescent patients.

KW - endoscopy

KW - fecal calprotectin

KW - symptom score

UR - http://www.scopus.com/inward/record.url?scp=85065310038&partnerID=8YFLogxK

U2 - 10.1097/MPG.0000000000002244

DO - 10.1097/MPG.0000000000002244

M3 - Journal article

C2 - 30628981

AN - SCOPUS:85065310038

VL - 68

SP - 669

EP - 675

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 5

ER -

ID: 239619383